Cancer

Explore the complexities of Cancer research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against cancer with flcube.com.

Boehringer Ingelheim Launches AIRWARD Phase III Trial of Verducatib – First Oral DPP1 Inhibitor to Reach Phase III in COPD
CompanyDrug

Boehringer Ingelheim Launches AIRWARD Phase III Trial of Verducatib – First Oral DPP1 Inhibitor to Reach Phase III in COPD

Boehringer Ingelheim announced the initiation of the AIRWARD Phase III clinical study, evaluating verducatib, an investigational oral dipeptidyl peptidase‑1 (DPP1) inhibitor, in adult patients with chronic obstructive pulmonary disease (COPD)…

Lynk Pharmaceuticals Expands Commercialization Partnership with Simcere – Exclusive Greater China Rights for Zemprocitinib Extended to Atopic Dermatitis and Dermatological Indications

Lynk Pharmaceuticals Expands Commercialization Partnership with Simcere – Exclusive Greater China Rights for Zemprocitinib Extended to Atopic Dermatitis and Dermatological Indications

Lifetech Scientific Wins CE MDR Certification for IBS Absorbable Drug‑Eluting Coronary Stent – World's First Iron‑Based Bioresorbable Coronary Stent Approved

Lifetech Scientific Wins CE MDR Certification for IBS Absorbable Drug‑Eluting Coronary Stent – World’s First Iron‑Based Bioresorbable Coronary Stent Approved

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Company

Sanofi’s Commitment to China: Expansion, Digital Innovation, and Local R&D

CompanyDrug

Chia Tai Tianqing’s Biosimilar Rituximab Approved by China’s NMPA for Lymphoma Treatments

CompanyDeals

Galvanize Therapeutics Partners with Energenx Medical for Greater China Expansion

CompanyDrug

AstraZeneca Launches Calquence in China for Mantle Cell Lymphoma Treatment

CompanyDrug

Hisun Pharmaceutical’s SHP2 Inhibitor HS336 Gets NMPA Clinical Trial Approval

CompanyDrug

Harbour Biomed’s Porustobart Combo Shows Promise in HCC Treatment, ASCO Presentation Reveals

CompanyDrug

Ascentage Pharma’s Olverembatinib Earns Breakthrough Designation for SDH-Deficient GIST

CompanyDrug

Abbisko Therapeutics Reports Positive Phase Ib Results for ABSK021 at ASCO

Show More